E-LIB Suche - Ergebnisse für: van Tellingen, O.

1

Fractionated brain X-irradiation profoundly reduces hippoca..:

Kuil, L.E. ; Seigers, R. ; Loos, M....
Heliyon. 10 (2024) 9 - p. e29947 , 2024

Link: https://doi.org/10.1016/..

2

P10.33.A TARGETED INHIBITION OF THREE MAJOR PROLIFERATION P..:

Baltira, C ; Mayayo-Peralta, I ; Guillén-Navarro, M...
Neuro-Oncology. 25 (2023) Supplement_2 - p. ii70-ii70 , 2023

Link: https://doi.org/10.1093/..

3

A validated HPLC-MS/MS method for simultaneously analyzing ..:

Kroon, M.A.G.M. ; van Laarhoven, H.W.M. ; Swart, E.L...
Heliyon. 9 (2023) 5 - p. e15540 , 2023

Link: https://doi.org/10.1016/..

4

P03.13.B RADIOTHERAPY-INDUCED COGNITIVE IMPAIRMENT IN CANCE..:

Kuil, L E ; de Gooijer, M C ; van Heijningen, C...
Neuro-Oncology. 25 (2023) Supplement_2 - p. ii39-ii39 , 2023

Link: https://doi.org/10.1093/..

5

P03.11.B MITOTIC ENRICHMENT AS AN EFFICIENT RADIOSENSITIZAT..:

de Gooijer, M C ; Çolakoğlu, H ; Çitirikkaya, C H...
Neuro-Oncology. 25 (2023) Supplement_2 - p. ii38-ii39 , 2023

Link: https://doi.org/10.1093/..

6

P10.28.B INTERMODEL VARIATION OF BBB PERMEABILITY AFFECTS C..:

Ntafoulis, I ; Koolen, S L W ; den Hollander, C W J...
Neuro-Oncology. 25 (2023) Supplement_2 - p. ii69-ii69 , 2023

Link: https://doi.org/10.1093/..

7

P10.21.A THE ABCB1/ABCG2 INHIBITOR ELACRIDAR IS A MORE POTE..:

Lentzas, A ; de Gooijer, M C ; Zuidema, S...
Neuro-Oncology. 25 (2023) Supplement_2 - p. ii67-ii67 , 2023

Link: https://doi.org/10.1093/..

8

P10.32.B SCREENING FOR OPTIMAL MULTI-TARGET DRUG COMBINATIO..:

Their, A ; Baltira, C ; Rozing, K...
Neuro-Oncology. 25 (2023) Supplement_2 - p. ii70-ii70 , 2023

Link: https://doi.org/10.1093/..

9

The ABCB1/ABCG2 inhibitor elacridar is a more potent pharma..:

Van Tellingen, O. ; Lentzas, A. ; Zuidema, S....
European Journal of Cancer. 174 (2022) - p. S103 , 2022

Link: https://doi.org/10.1016/..

10

Clinical impact of using sensitive LC-MSMS based testostero..:

Van Rossum, H. ; Van Winden, L. ; Lanfermeijer, M....
Clinica Chimica Acta. 493 (2019) - p. S72 , 2019

Link: https://doi.org/10.1016/..

11

P04.91ABC-drug efflux transporters at the blood-brain barri..:

van Tellingen, O ; de Gooijer, M C ; Buil, L C M...
Neuro-Oncology. 20 (2018) suppl_3 - p. iii301-iii302 , 2018

Link: https://doi.org/10.1093/..

12

16 Quadruple vertical targeting of an oncogenic pathway as ..:

Neto, J. ; Van Tellingen, O. ; Villanueva, A..
ESMO Open. 3 (2018) - p. A7-A8 , 2018

Link: https://doi.org/10.1136/..

13

Neurobiological changes by cytotoxic agents in mice:

Seigers, R. ; Loos, M. ; Van Tellingen, O....
Behavioural Brain Research. 299 (2016) - p. 19-26 , 2016

Link: https://doi.org/10.1016/..

14

Overcoming the blood–brain tumor barrier for effective glio..:

van Tellingen, O. ; Yetkin-Arik, B. ; de Gooijer, M.C....
Drug Resistance Updates. 19 (2015) - p. 1-12 , 2015

Link: https://doi.org/10.1016/..

15

Strategies to target drugs to gliomas and CNS metastases of..:

Milojkovic Kerklaan, B. ; van Tellingen, O. ; Huitema, A. D. R....
Journal of Neurology. 263 (2015) 3 - p. 428-440 , 2015

Link: https://doi.org/10.1007/..